No Data
No Data
QSAM Biosciences Announces 1-for-1,000 to 1-for-2,000 Reverse Stock Split Ahead of Merger With Telix >QSAM
Express News | Qsam Announces Reverse Stock Split Ratio Ahead of Merger
Radiopharmaceutical Market Expected to Reach ~$14B by 2032
QSAM to Be Acquired by Telix for $33.1M Plus $90M CVR
Express News | QSAM Biosciences Signs Definitive Agreement To Be Acquired By Telix Pharmaceuticals; QASM Shareholders To Receive $33.1M In Telix Ordinary Shares and CVRs To Receive Up To $90M In Future Payments Upon Milestonesa
QSAM Biosciences Signs Definitive Agreement To Be Acquired By Telix Pharmaceuticals >QSAM